CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Universidade de São Paulo (USP). Instituto de Química (IQ) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Graduated in Marine Sciences from Universidade do Porto, Portugal (1993) and Ph.D. in Biochemistry from Universidade de São Paulo (2000). Visiting Scientist at Cold Spring Harbor Laboratory, NY- EUA from 08/2008 to 02/2010. Research areas in Molecular Biology and Genomics, focusing on large-scale analysis of gene expression, molecular markers of cancer, noncoding RNAs. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Melanoma is one of the most aggressive and therapy-resistant neoplasias. Despite advances achieved through the development of targeted therapies, such as BRAF and MEK inhibitors, and immunotherapies, such as anti-CTLA4 and anti-PD1, which have resulted in increased survival of patients with malignant melanoma, around 50% of these develop resistance to treatments. The characteristic phenot…
Pancreatic cancer is one of the most lethal neoplasms and only 5% of affected individuals survive more than 5 years after diagnosis, with ductal adenocarcinoma (PDAC) being the most prevalent and aggressive type. Chemotherapy with gemcitabine is the standard treatment protocol for invasive PDAC and is also used as adjuvant therapy after surgical removal of the tumor. However, the clinical…
(Only some records are available in English at this moment)
Pancreatic cancer, glioblastoma, and melanoma pose significant challenges in the oncology field, with considerable mortality rates and complexities in clinical management. Despite advancements in understanding tumorigenic mechanisms, therapeutic resistance, especially related to cancer stem cells (CSCs), remains an obstacle. Considering the impact of long non-coding RNAs (lncRNAs) on biol…
Pancreatic ductaladenocarcinoma (PCA) is a highly lethal cancer for which there are no effectivetherapies. Omics approaches have been widely used to characterize the molecularprofile of PCA in search of vulnerabilities that indicate new targets fortreatment. Long non-coding RNAs (LncRNAs) are encoded by 60% of human genes andcan regulate several cellular processes, such as chromatin regul…
This project aims to investigate the contribution of long non-coding RNAs (lncRNAs) to epigenetic reprogramming and control of gene expression in Pancreatic Ductal Adenocarcinoma (PDAC). The hypothesis that motivates this study is that lncRNAs can interact with components of the epigenetic machinery, directing it to specific loci in order to modify chromatin activation/repression states, …
The project aims to generate immortalized PDAC cell lines resistant to gemcitabine, and the molecular characterization of this resistance. Such lines will be generated by prolonged treatments under sub-lethal concentrations of the drug and will have their resistance evaluated by determining the expression of resistance marker genes already described in the literature by RT-qPCR. In additi…
Aging related diseases are the leading cause of death in the world. This study aims to investigate molecular aspects of innate immunity in the senescence process, and as a predisposition factor for the development of sepsis, a complex disease associated with aging. We will perform a broad gene expression analysis to identify genes with a critical role in the aging process and to investiga…
(Only some records are available in English at this moment)
Recent studies have shown that most of the eukaryotic genome is transcribed as noncoding RNAs (ncRNAs). Although it is clear that different classes of ncRNAs play fundamental roles in the control of gene expression, only a small fraction of the noncoding fraction of the transcriptome has been functionally characterized. This research proposal will employ molecular and cellular biology app…
| 1 / 1 | Ongoing grants |
| 11 / 8 | Completed research grants |
| 2 / 2 | Ongoing scholarships in Brazil |
| 17 / 9 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 32 / 21 | All research grants and scholarships |
| Associated processes | |